{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T20:10:41Z","timestamp":1722197441025},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,28]]},"DOI":"10.7759\/cureus.65592","type":"journal-article","created":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T19:53:47Z","timestamp":1722196427000},"source":"Crossref","is-referenced-by-count":0,"title":["Relapsed Gray Zone Lymphoma: A Rare Clinical Challenge"],"prefix":"10.7759","author":[{"given":"Pratyaksh","family":"Chhabra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prerna","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishaan M","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakriti","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhushan","family":"Madke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Lymphoma","author":"Jamil A","unstructured":"Jamil A, Mukkamalla SK. Lymphoma. StatPearls [Internet]. StatPearls [Internet], Treasure Island (FL); 2024."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pop.2016.07.012","article-title":"Lymphoma","volume":"43","author":"Mugnaini EN","year":"2016","unstructured":"Mugnaini EN, Ghosh N. Lymphoma. Prim Care. 2016, 43:661-75. 10.1016\/j.pop.2016.07.012","journal-title":"Prim Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2003.10.025","article-title":"The Hodgkin and Reed\/Sternberg cell","volume":"37","author":"K\u00fcppers R","year":"2005","unstructured":"K\u00fcppers R, Hansmann ML. The Hodgkin and Reed\/Sternberg cell. Int J Biochem Cell Biol. 2005, 37:511-7. 10.1016\/j.biocel.2003.10.025","journal-title":"Int J Biochem Cell Biol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2015.01.006","article-title":"The histological classification of diffuse large B-cell lymphomas","volume":"52","author":"Xie Y","year":"2015","unstructured":"Xie Y, Pittaluga S, Jaffe ES. The histological classification of diffuse large B-cell lymphomas. Semin Hematol. 2015, 52:57-66. 10.1053\/j.seminhematol.2015.01.006","journal-title":"Semin Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-01962-5","article-title":"Correction: \u201cThe 5th edition of the World Health Organization classification of Haematolymphoid tumours: lymphoid neoplasms\u201d leukemia. 2022 Jul; 36(7):1720-1748","volume":"37","author":"Alaggio R","year":"2023","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, et al.. Correction: \u201cThe 5th edition of the World Health Organization classification of Haematolymphoid tumours: lymphoid neoplasms\u201d leukemia. 2022 Jul; 36(7):1720-1748. Leukemia. 2023, 37:1944-51. 10.1038\/s41375-023-01962-5","journal-title":"Leukemia"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.12.471","article-title":"Trends and outcomes of gray zone lymphoma in the United States: a population-based registry study","volume":"26","author":"Qasrawi A","year":"2020","unstructured":"Qasrawi A, Swofford B, Abughanimeh O, Hildebrandt GC. Trends and outcomes of gray zone lymphoma in the United States: a population-based registry study. Biol Blood Marrow Transplant. 2020, 26:230. 10.1016\/j.bbmt.2019.12.471","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.lrr.2023.100372","article-title":"Gray zone lymphoma: a case report and comprehensive review of literature","volume":"19","author":"Uczkowski D","year":"2023","unstructured":"Uczkowski D, Ashraf H, Cherry M, Dimov N. Gray zone lymphoma: a case report and comprehensive review of literature. Leuk Res Rep. 2023, 19:100372. 10.1016\/j.lrr.2023.100372","journal-title":"Leuk Res Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.043026","article-title":"Mediastinal gray zone lymphoma","volume":"96","author":"Quintanilla-Martinez L","year":"2011","unstructured":"Quintanilla-Martinez L, Fend F. Mediastinal gray zone lymphoma. Haematologica. 2011, 96:496-9. 10.3324\/haematol.2011.043026","journal-title":"Haematologica"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2020.1696186","article-title":"Into the gray-zone: update on the diagnosis and classification of a rare lymphoma","volume":"13","author":"Egan C","year":"2020","unstructured":"Egan C, Pittaluga S. Into the gray-zone: update on the diagnosis and classification of a rare lymphoma. Expert Rev Hematol. 2020, 13:1-3. 10.1080\/17474086.2020.1696186","journal-title":"Expert Rev Hematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017009472","article-title":"Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL","volume":"1","author":"Pilichowska M","year":"2017","unstructured":"Pilichowska M, Pittaluga S, Ferry JA, et al.. Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL. Blood Adv. 2017, 1:2600-9. 10.1182\/bloodadvances.2017009472","journal-title":"Blood Adv"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-564906","article-title":"A prospective study of mediastinal gray-zone lymphoma","volume":"124","author":"Wilson WH","year":"2014","unstructured":"Wilson WH, Pittaluga S, Nicolae A, et al.. A prospective study of mediastinal gray-zone lymphoma. Blood. 2014, 124:1563-9. 10.1182\/blood-2014-03-564906","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24082","article-title":"Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort","volume":"90","author":"Evens AM","year":"2015","unstructured":"Evens AM, Kanakry JA, Sehn LH, et al.. Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort. Am J Hematol. 2015, 90:778-83. 10.1002\/ajh.24082","journal-title":"Am J Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/274088-relapsed-gray-zone-lymphoma-a-rare-clinical-challenge","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T19:53:50Z","timestamp":1722196430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/274088-relapsed-gray-zone-lymphoma-a-rare-clinical-challenge"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,28]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.65592","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,28]]}}}